(Q50648020)

17 March 2018

title

Eculizumab, a terminal complement inhibitor, improves anaemia in patients with paroxysmal nocturnal haemoglobinuria. (English)

1 reference

17 March 2018

author

Jeff Szer

6

1 reference

17 March 2018

Paul V. Browne

9

1 reference

17 March 2018

Gérard Socié

8

object named as

Gérard Socié

1 reference

17 March 2018

12

Petra Muus

1 reference

17 March 2018

author name string

Jörg Schubert

1

1 reference

17 March 2018

Peter Hillmen

2

1 reference

17 March 2018

Alexander Röth

3

1 reference

17 March 2018

Neal S Young

4

1 reference

17 March 2018

Modupe O Elebute

5

1 reference

17 March 2018

Giacomo Gianfaldoni

7

1 reference

17 March 2018

Robert Geller

10

1 reference

17 March 2018

Russell P Rother

11

1 reference

17 March 2018

TRIUMPH Study Investigators

13

1 reference

17 March 2018

language of work or name

English

0 references

publication date

22 May 2008

1 reference

17 March 2018

British Journal of Haematology

published in

1 reference

17 March 2018

volume

142

1 reference

17 March 2018

issue

2

1 reference

17 March 2018

page(s)

263-272

1 reference

17 March 2018

Inherited complete deficiency of 20-kilodalton homologous restriction factor (CD59) as a cause of paroxysmal nocturnal hemoglobinuria

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07183.X

Sustained response and long-term safety of eculizumab in paroxysmal nocturnal hemoglobinuria

21 January 2018

1 reference

12 December 2020

Fatigue in cancer patients compared with fatigue in the general United States population.

1 reference

12 December 2020

Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria.

1 reference

12 December 2020

Erythopoietin treatment during complement inhibition with eculizumab in a patient with paroxysmal nocturnal hemoglobinuria.

1 reference

12 December 2020

Paroxysmal nocturnal hemoglobinuria due to hereditary nucleotide deletion in the HRF20 (CD59) gene

1 reference

12 December 2020

Expression of glycosyl-phosphatidylinositol-linked glycoproteins in blood cells from paroxysmal nocturnal haemoglobinuria patients: a flow cytometry study using CD55, CD58 and CD59 monoclonal antibodies

1 reference

12 December 2020

The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease

1 reference

12 December 2020

The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria

1 reference

12 December 2020

Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria

1 reference

12 December 2020

The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria

1 reference

12 December 2020

Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria

1 reference

12 December 2020

Blood cell flow cytometry in paroxysmal nocturnal hemoglobinuria: a tool for measuring the extent of the PNH clone

1 reference

12 December 2020

Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene

1 reference

12 December 2020

A mathematical model for the evaluation of amplitude of hemoglobin fluctuations in elderly anemic patients affected by myelodysplastic syndromes: correlation with quality of life and fatigue.

1 reference

12 December 2020

A simplified assay for the specific diagnosis of paroxysmal nocturnal hemoglobinuria: detection of DAF(CD55)- and HRF20(CD59)- erythrocytes in microtyping cards

1 reference

12 December 2020

Clinical manifestations of paroxysmal nocturnal hemoglobinuria: present state and future problems

1 reference

12 December 2020

Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv.

1 reference

12 December 2020

Diagnosis and management of paroxysmal nocturnal hemoglobinuria

1 reference

12 December 2020

10.1111/J.1365-2141.2008.07183.X

Identifiers

DOI

1 reference

17 March 2018

PubMed ID

18503589

1 reference

17 March 2018